Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Immatics Biotech begins phase III IMA-901 trial in renal cell carcinoma

Dec. 31, 2010

Medimmune begins phase Ib/II trial of MEDI-575 in NSCLC

Dec. 31, 2010

BioCancell Therapeutics completes preclinical studies of BC-821 for glioblastoma

Dec. 31, 2010

HER2-Affitoxin is a potential therapeutic for HER2-overexpressing tumors

Dec. 31, 2010

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Bristol-Myers Squibb and Otsuka to copromote Sprycel in Japan

Dec. 30, 2010

Phase I/II trial of belinostat/Tarceva combination in NSCLC advances

Dec. 30, 2010

Ziopharm Oncology treats first patient in phase I trial of palifosfamide

Dec. 30, 2010

New inhibitors of focal adhesion kinase 1 claimed

Dec. 30, 2010

MK-0752 shows promise in patients with breast cancer

Dec. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...